praziquantel and Brain Disorders studies

Research Excerpts

Excerpt	Relevance	Reference
"A recently described one-day regimen of praziquantel (PZQ) therapy for neurocysticercosis (NCC), three doses of 25 mg/k given at 2 h intervals, was applied in eight patients with viable NCC cysts without any evidence of inflammation."	9.09	Failure of one-day praziquantel treatment in patients with multiple neurocysticercosis lesions. ( García, HH; Gilman, RH; Martinez, M; Pretell, EJ; Saavedra, H, 2001)
"The purpose of this study was to determine the therapeutic efficacy of albendazole and praziquantel administration in the treatment of neurocysticercosis of the fourth ventricle."	9.08	Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle. ( Correa, D; García, L; García-Torres, E; Madrazo, I; Proaño, JV, 1997)
"Praziquantel and albendazole have been recently described as effective drugs for treatment of intraparenchymal brain cysticercosis."	9.07	Therapy for neurocysticercosis. Comparison between albendazole and praziquantel. ( Jardim, E; Takayanagui, OM, 1992)
"One hundred consecutive patients presenting with symptoms and signs of neurocysticercosis, confirmed by neuroimaging techniques were randomly assigned to treatment with either praziquantel 50 mg/kg/day for 15 days or albendazole 15 mg/kg/day for 30 days."	9.07	Clinical evaluation of albendazole and praziquantel in the treatment of cerebral cysticercosis. ( Cruz, I; Cruz, M; Horton, J, 1991)
"The results of the use of praziquantel (PZQ) for the etiologic treatment of neurocysticercosis (NC) are presented."	9.06	[Neurocysticercosis. II. Evaluation of treatment with praziquantel]. ( Takayanagui, OM, 1990)
"In a prospective study, 17 Brazilian patients with parenchymatous neurocysticercosis were monitored for a period of 12 months after treatment with praziquantel."	7.69	Clinical and immunologic follow-up study of patients with neurocysticercosis after treatment with praziquantel. ( Bedaque, EA; Feldmeier, H; Jansen-Rosseck, R; Kremsner, P; Martins, AR; Mühlschlegel, F; Pedretti, L; Rolfs, A; Schulte, G; Tamburus, WM, 1995)
"We report a patient with cerebral cysticercosis treated with praziquantel."	7.69	[Cerebral cysticercosis treated with praziquantel--a case report]. ( Inaba, M; Shimamoto, Y; Shimazaki, K; Shinoda, J; Sugiyama, E; Yamada, F, 1994)
"A patient had neurocysticercosis complicated by a seizure disorder requiring anticonvulsants; previous praziquantel therapy (50 mg/kg/day) had failed to eradicate the disease."	7.69	Cimetidine-induced rise in praziquantel levels in a patient with neurocysticercosis being treated with anticonvulsants. ( Adubofour, KO; Bikin, DS; Dachman, WD; Johnson, CH; Mullin, PD; Winograd, M, 1994)
"A 59-year-old man with known neurocysticercosis developed a large cerebral infarction during praziquantel therapy."	7.69	Large cerebral infarction during praziquantel therapy in neurocysticercosis. ( Bang, OY; Choi, SA; Heo, JH; Kim, DI, 1997)
"Eight patients with neurocysticercosis treated with praziquantel (PZQ) were studied with serial MR imaging to demonstrate the early effects of the drug in brain lesions."	7.68	MR observations on the effects of praziquantel in neurocysticercosis. ( Gupta, AK; Jain, RK; Jena, A; Sanchetee, PC; Sapra, ML; Tripathi, R, 1992)
"The neuropathological findings in a fatal case of neurocysticercosis treated with praziquantel are reported in this paper."	7.68	[Neurocysticercosis: neuropathologic study of a fatal case treated with praziquantel]. ( Andrade Filho, Ade S; de Queiroz, AC, 1991)
"The CSF and plasma concentrations of praziquantel (PZQ) were determined with high pressure liquid chromatography in 37 patients with cysticercosis of the central nervous system during a dosing regimen of PZQ 20 mg/kg p o q 8h for 3 days."	7.68	[Determination of praziquantel levels in cerebrospinal fluid and plasma in patients with cysticercosis of the central nervous system treated with praziquantel]. ( Jia, JY, 1991)
"Albendazole or praziquantel were measured in plasma and cerebrospinal fluid (CSF) in 29 patients with neurocysticercosis."	7.68	Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosis. ( Hurtado, M; Jung, H; Medina, MT; Sanchez, M; Sotelo, J, 1990)
"A patient with neurocysticercosis was successfully treated with praziquantel."	7.67	Successful treatment of neurocysticercosis with low-dose praziquantel. ( Pun, KK; Wong, WT, 1984)
"Twenty-six patients with cysticercosis of the brain parenchyma were treated with the antihelmintic agent praziquantel (50 mg per kilogram of body weight daily for 15 days)."	7.67	Therapy of parenchymal brain cysticercosis with praziquantel. ( Escobedo, F; Rodriguez-Carbajal, J; Rubio-Donnadieu, F; Sotelo, J; Torres, B, 1984)
"Thirty-three patients with confirmed cysticercosis, with or without cerebral involvement, were treated with praziquantel at a daily dose of 75 mg/kg tid for 3 to 10 consecutive days and evaluated for tolerance and therapeutic effects."	7.67	Clinical evaluation of the therapeutic efficacy of praziquantel against human cysticercosis. ( Joo, KH; Rim, HJ, 1989)
"The humoral immune response to treatment with praziquantel (PZQ) was studied in eight patients with parenchymal cerebral cysticercosis (CC)."	7.67	Humoral immune response in patients with cerebral parenchymal cysticercosis treated with praziquantel. ( Corona, T; Estañol, B; González-Barranco, D; Irigoyen, Mdel C; Juárez, H, 1989)
"A prospective open therapeutic study on volunteers with active neurocysticercosis using pyrazinoisoquinolone (Praziquantel) has shown that it is a safe and effective drug."	7.67	Praziquantel (pyrazinoisoquinolone) in active cerebral cysticercosis. ( McKeown, CP; van Dellen, JR, 1988)
"Praziquantel and albendazole have been recently described as effective drugs for treating cysticercosis of the brain."	7.67	Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial. ( Escobedo, F; Penagos, P; Sotelo, J, 1988)
"A patient who developed a cerebral infarct during the course of praziquantel therapy for neurocysticercosis is described."	7.67	Cerebral infarct precipitated by praziquantel in neurocysticercosis--a cautionary note. ( Huang, CY; Woo, E; Yu, YL, 1988)
"The selective use of praziquantel for the treatment of brain cysticercosis in human beings is described, based upon the results of clinical tests conducted during a 2 year period."	7.67	Selective indications for the use of praziquantel in the treatment of brain cysticercosis. ( Cruz-Segura, H; Mateos-Gomez, H; Vasconcelos, D; Zenteno Alanis, G, 1987)
"Praziquantel therapy has produced a much better prognosis in neurocysticercosis since 1980."	7.67	[CT follow-up of neurocysticercosis treated with praziquantel]. ( Aulich, A; Hammer, B; Schwartz, A, 1987)
"An infant with cerebral cysticercosis had marked clinical and radiographic improvement following treatment with praziquantel."	7.67	Cerebral cysticercosis: treatment with praziquantel. ( Kapadia, C; Norman, RM, 1986)
"The long-term results of praziquantel therapy in 141 patients with neurocysticercosis are presented."	7.67	Long-term results of praziquantel therapy in neurocysticercosis. ( Galindo-Virgen, S; Robles, C; Sedano, AM; Vargas-Tentori, N, 1987)
"Seven patients with chronic parenchymal brain cysticercosis were treated with albendazole for one month at daily doses of 15 mg/kg of body weight."	7.67	Albendazole therapy for neurocysticercosis. ( Escobedo, F; Penagos, P; Rodriguez, J; Sotelo, J, 1987)
"Thirty-five patients with active neurocysticercosis were treated with praziquantel and followed for 1 year after therapy."	7.67	Praziquantel in the treatment of neurocysticercosis: long-term follow-up. ( Escobedo, F; Rodriguez-Carbajal, J; Rubio-Donnadieu, F; Sotelo, J; Torres, B, 1985)
"This paper summarizes the experience with Praziquantel, a new broad spectrum antihelmintic for the treatment of neurocysticercosis."	7.66	Medical management of neurocysticercosis with Praziquantel. ( Lawner, PM, 1983)
"A patient with cerebral cysticercosis had marked clinical and radiographic response to the administration of corticosteroids and praziquantel."	7.66	Cerebral cysticercosis treated biphasically with dexamethasone and praziquantel. ( deGhetaldi, LD; Douville, AW; Norman, RM, 1983)
"Treatment with praziquantel resulted in the regression of only some of the cysts."	5.28	[Selective sensitivity of cysts to praziquantel and albendazole in a case of cerebral cysticercosis]. ( Belec, L; Cohen, L; Pierrot-Deseilligny, C; Sanson, M; Signoret, JL, 1992)
"Praziquantel was given orally at a dosage of 45 mg/kg/day in 3 divided doses at 4-5 hour interval for 15 days."	5.28	The treatment of neurocysticercosis with praziquantel. ( Bunnag, D; Riganti, M; Vanijanonta, S, 1991)
"Praziquantel (PZQ) was administered to the patients at their admission to the study."	5.28	[Neurocysticercosis and praziquantel: long-term development in 100 patients]. ( Livramento, JA; Machado, LR; Nóbrega, JP; Spina-França, A, 1989)
"Treatment with praziquantel was given at 35 mg/day for 10 days, dexamethasone and carbamazepine were also given to reduce side effects."	5.27	Subcutaneous and cerebral cysticercosis treated with praziquantel. ( Conde, J; Cross, JH; Quimosing, EM, 1984)
"Treatment with praziquantel 50 mg/kg body weight daily for 14 days resulted in clinical and radiological improvement in the first patient, although she obviously still harbored a number of viable non-calcified parasites."	5.27	Cerebral cysticercosis: treatment with praziquantel. Report of two cases. ( Hess, K; Markwalder, K; Valavanis, A; Witassek, F, 1984)
"By treatment with praziquantel there was an essential improvement of seizure frequency and headaches."	5.27	[Cerebral cysticercosis. A report on the treatment with praziquantel]. ( Maier-Metz, F; Meyer-Wahl, JG, 1984)
"Cysticercosis is the most common parasitosis affecting the central nervous system and it is endemic in many countries."	5.27	Brain cysticercosis treated with praziquantel. Report of six cases. ( Abad, JM; Bollar, A; Fernańdez, J; García-Allut, A; Gelabert, M; Mostaza, A, 1988)
"Cerebral cysticercosis was diagnosed with computed tomography (CT) scan, showing signs of intracranial hypertension and cystic lesions, and was confirmed by serological investigation."	5.27	Cerebral cysticercosis successfully treated with praziquantel. ( Braconier, JH; Christensson, B, 1988)
"Neurocysticercosis is not uncommon in the immigrant population of large North American cities."	5.27	Neurocysticercosis: surgical and medical management with praziquantel. ( Farmer, JP; Knowles, KF; Leblanc, R; MacLean, JD; Melanson, D; Rouleau, G, 1986)
"A recently described one-day regimen of praziquantel (PZQ) therapy for neurocysticercosis (NCC), three doses of 25 mg/k given at 2 h intervals, was applied in eight patients with viable NCC cysts without any evidence of inflammation."	5.09	Failure of one-day praziquantel treatment in patients with multiple neurocysticercosis lesions. ( García, HH; Gilman, RH; Martinez, M; Pretell, EJ; Saavedra, H, 2001)
"Randomized clinical trial of treatment of patients with newly identified active neurocysticercosis with oral prednisolone alone (27 patients), praziquantel with prednisolone (54 patients), or albendazole with prednisolone (57 patients)."	5.08	Is the course of neurocysticercosis modified by treatment with antihelminthic agents? ( Carpio, A; Flores, C; Hauser, WA; León, P; Santillán, F, 1995)
"Plasma praziquantel concentrations were measured in 11 Thai patients with active neurocysticercosis (8 males and 3 females)."	5.08	Plasma concentrations of praziquantel during the therapy of neurocysticerosis with praziquantel, in the presence of antiepileptics and dexamethasone. ( Karbwang, J; Na-Bangchang, K; Vanijanonta, S, 1995)
"The purpose of this study was to determine the therapeutic efficacy of albendazole and praziquantel administration in the treatment of neurocysticercosis of the fourth ventricle."	5.08	Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle. ( Correa, D; García, L; García-Torres, E; Madrazo, I; Proaño, JV, 1997)
"Praziquantel and albendazole have been recently described as effective drugs for treatment of intraparenchymal brain cysticercosis."	5.07	Therapy for neurocysticercosis. Comparison between albendazole and praziquantel. ( Jardim, E; Takayanagui, OM, 1992)
"One hundred consecutive patients presenting with symptoms and signs of neurocysticercosis, confirmed by neuroimaging techniques were randomly assigned to treatment with either praziquantel 50 mg/kg/day for 15 days or albendazole 15 mg/kg/day for 30 days."	5.07	Clinical evaluation of albendazole and praziquantel in the treatment of cerebral cysticercosis. ( Cruz, I; Cruz, M; Horton, J, 1991)
"The efficacy of different regimens of therapy for parenchymal brain cysticercosis either with praziquantel (PZQ) or with albendazole (ALB) was compared in 114 patients."	5.06	Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. ( del Brutto, OH; Escobedo, F; Penagos, P; Rodriguez-Carbajal, J; Rubio-Donnadieu, F; Sotelo, J; Torres, B, 1990)
"The results of the use of praziquantel (PZQ) for the etiologic treatment of neurocysticercosis (NC) are presented."	5.06	[Neurocysticercosis. II. Evaluation of treatment with praziquantel]. ( Takayanagui, OM, 1990)
" Neurocysticercosis was confirmed by repeated, significantly positive serology results and the dramatic response to praziquantel."	4.79	Distinctive serial magnetic resonance changes in a young woman with rapidly evolved neurocysticercosis, with positron emission tomography results. ( Izumi, Y; Nagakura, K; Nagayama, M; Shinohara, Y; Takagi, S, 1996)
" After the patient was firstly administered the antiparasitic treatment of cysticercosis (praziquantel), he had status epilepticus."	3.88	[Treatment and nursing of a cysticercosis patient with multiple foci]. ( Ji-Guang, D; Yu-Hua, F, 2018)
"In a prospective study, 17 Brazilian patients with parenchymatous neurocysticercosis were monitored for a period of 12 months after treatment with praziquantel."	3.69	Clinical and immunologic follow-up study of patients with neurocysticercosis after treatment with praziquantel. ( Bedaque, EA; Feldmeier, H; Jansen-Rosseck, R; Kremsner, P; Martins, AR; Mühlschlegel, F; Pedretti, L; Rolfs, A; Schulte, G; Tamburus, WM, 1995)
"We report a patient with cerebral cysticercosis treated with praziquantel."	3.69	[Cerebral cysticercosis treated with praziquantel--a case report]. ( Inaba, M; Shimamoto, Y; Shimazaki, K; Shinoda, J; Sugiyama, E; Yamada, F, 1994)
"A patient had neurocysticercosis complicated by a seizure disorder requiring anticonvulsants; previous praziquantel therapy (50 mg/kg/day) had failed to eradicate the disease."	3.69	Cimetidine-induced rise in praziquantel levels in a patient with neurocysticercosis being treated with anticonvulsants. ( Adubofour, KO; Bikin, DS; Dachman, WD; Johnson, CH; Mullin, PD; Winograd, M, 1994)
"A 59-year-old man with known neurocysticercosis developed a large cerebral infarction during praziquantel therapy."	3.69	Large cerebral infarction during praziquantel therapy in neurocysticercosis. ( Bang, OY; Choi, SA; Heo, JH; Kim, DI, 1997)
"420 patients with cerebral cysticercosis, including 97 with intracranial hypertension, were treated by praziquantel 30-50 mg/kg a day, 7-10 days a course."	3.68	[A follow-up study of 420 cases of cerebral cysticercosis]. ( Zhu, S, 1992)
"Eight patients with neurocysticercosis treated with praziquantel (PZQ) were studied with serial MR imaging to demonstrate the early effects of the drug in brain lesions."	3.68	MR observations on the effects of praziquantel in neurocysticercosis. ( Gupta, AK; Jain, RK; Jena, A; Sanchetee, PC; Sapra, ML; Tripathi, R, 1992)
"The neuropathological findings in a fatal case of neurocysticercosis treated with praziquantel are reported in this paper."	3.68	[Neurocysticercosis: neuropathologic study of a fatal case treated with praziquantel]. ( Andrade Filho, Ade S; de Queiroz, AC, 1991)
"The CSF and plasma concentrations of praziquantel (PZQ) were determined with high pressure liquid chromatography in 37 patients with cysticercosis of the central nervous system during a dosing regimen of PZQ 20 mg/kg p o q 8h for 3 days."	3.68	[Determination of praziquantel levels in cerebrospinal fluid and plasma in patients with cysticercosis of the central nervous system treated with praziquantel]. ( Jia, JY, 1991)
"Albendazole or praziquantel were measured in plasma and cerebrospinal fluid (CSF) in 29 patients with neurocysticercosis."	3.68	Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosis. ( Hurtado, M; Jung, H; Medina, MT; Sanchez, M; Sotelo, J, 1990)
"A patient with neurocysticercosis was successfully treated with praziquantel."	3.67	Successful treatment of neurocysticercosis with low-dose praziquantel. ( Pun, KK; Wong, WT, 1984)
"Twenty-six patients with cysticercosis of the brain parenchyma were treated with the antihelmintic agent praziquantel (50 mg per kilogram of body weight daily for 15 days)."	3.67	Therapy of parenchymal brain cysticercosis with praziquantel. ( Escobedo, F; Rodriguez-Carbajal, J; Rubio-Donnadieu, F; Sotelo, J; Torres, B, 1984)
"Thirty-three patients with confirmed cysticercosis, with or without cerebral involvement, were treated with praziquantel at a daily dose of 75 mg/kg tid for 3 to 10 consecutive days and evaluated for tolerance and therapeutic effects."	3.67	Clinical evaluation of the therapeutic efficacy of praziquantel against human cysticercosis. ( Joo, KH; Rim, HJ, 1989)
"The humoral immune response to treatment with praziquantel (PZQ) was studied in eight patients with parenchymal cerebral cysticercosis (CC)."	3.67	Humoral immune response in patients with cerebral parenchymal cysticercosis treated with praziquantel. ( Corona, T; Estañol, B; González-Barranco, D; Irigoyen, Mdel C; Juárez, H, 1989)
"Ten patients with cerebral cysticercosis seen between 1983 and 1986 were treated with praziquantel and in some cases by a ventriculoperitoneal shunt and/or surgical excision of cysts."	3.67	[Cerebral cysticercosis. 10 cases]. ( Botana, C; Fandiño, J; Gómez-Bueno, J; Pastor, A; Rodríguez, M; Viladrich, A, 1989)
"The effectiveness of standard single-day praziquantel treatment (60 mg/kg) was prospectively evaluated in nine patients with seizures caused by cerebral Schistosoma japonicum infection."	3.67	Praziquantel in treatment of cerebral schistosomiasis. ( Adapon, B; Cross, JH; Fernando, MT; Long, GW; Ranoa, CP; Watt, G, 1986)
"A prospective open therapeutic study on volunteers with active neurocysticercosis using pyrazinoisoquinolone (Praziquantel) has shown that it is a safe and effective drug."	3.67	Praziquantel (pyrazinoisoquinolone) in active cerebral cysticercosis. ( McKeown, CP; van Dellen, JR, 1988)
"Praziquantel and albendazole have been recently described as effective drugs for treating cysticercosis of the brain."	3.67	Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial. ( Escobedo, F; Penagos, P; Sotelo, J, 1988)
"A patient who developed a cerebral infarct during the course of praziquantel therapy for neurocysticercosis is described."	3.67	Cerebral infarct precipitated by praziquantel in neurocysticercosis--a cautionary note. ( Huang, CY; Woo, E; Yu, YL, 1988)
"The selective use of praziquantel for the treatment of brain cysticercosis in human beings is described, based upon the results of clinical tests conducted during a 2 year period."	3.67	Selective indications for the use of praziquantel in the treatment of brain cysticercosis. ( Cruz-Segura, H; Mateos-Gomez, H; Vasconcelos, D; Zenteno Alanis, G, 1987)
"Praziquantel therapy has produced a much better prognosis in neurocysticercosis since 1980."	3.67	[CT follow-up of neurocysticercosis treated with praziquantel]. ( Aulich, A; Hammer, B; Schwartz, A, 1987)
"Treatment with praziquantel for neurocysticercosis frequently induces adverse reactions due to acute destruction of parasites; these reactions are suppressed by dexamethasone therapy."	3.67	Plasma levels of praziquantel decrease when dexamethasone is given simultaneously. ( Jung, H; Sotelo, J; Vazquez, ML, 1987)
"An infant with cerebral cysticercosis had marked clinical and radiographic improvement following treatment with praziquantel."	3.67	Cerebral cysticercosis: treatment with praziquantel. ( Kapadia, C; Norman, RM, 1986)
"The long-term results of praziquantel therapy in 141 patients with neurocysticercosis are presented."	3.67	Long-term results of praziquantel therapy in neurocysticercosis. ( Galindo-Virgen, S; Robles, C; Sedano, AM; Vargas-Tentori, N, 1987)
"Seven patients with chronic parenchymal brain cysticercosis were treated with albendazole for one month at daily doses of 15 mg/kg of body weight."	3.67	Albendazole therapy for neurocysticercosis. ( Escobedo, F; Penagos, P; Rodriguez, J; Sotelo, J, 1987)
"Thirty-five patients with active neurocysticercosis were treated with praziquantel and followed for 1 year after therapy."	3.67	Praziquantel in the treatment of neurocysticercosis: long-term follow-up. ( Escobedo, F; Rodriguez-Carbajal, J; Rubio-Donnadieu, F; Sotelo, J; Torres, B, 1985)
"This paper summarizes the experience with Praziquantel, a new broad spectrum antihelmintic for the treatment of neurocysticercosis."	3.66	Medical management of neurocysticercosis with Praziquantel. ( Lawner, PM, 1983)
"A patient with cerebral cysticercosis had marked clinical and radiographic response to the administration of corticosteroids and praziquantel."	3.66	Cerebral cysticercosis treated biphasically with dexamethasone and praziquantel. ( deGhetaldi, LD; Douville, AW; Norman, RM, 1983)
"Cerebral schistosomiasis is a rare but important consideration in the list of differential diagnoses of cerebral space-occupying lesions."	2.72	Surgical management outcome of cerebral schistosomiasis: a case report and review of the literature. ( Ahmed, MMZ; Ginawi, A; Mohamed, AHA; Osman, HHM, 2021)
"Neurocysticercosis is a parasitic infection of the central nervous system by the larval stage of the pork tapeworm and is a common cause of seizures and epilepsy in endemic areas."	2.72	Anthelmintics for people with neurocysticercosis. ( Abba, K; Monk, EJM; Ranganathan, LN, 2021)
"Sheep (n = 14) with coenuriosis were treated with praziquantel in single or divided doses at total dosage rates of 50 to 500 mg kg-1 live mass."	2.67	Treatment of cerebral coenuriosis in sheep with praziquantel. ( Tustin, RC; Verster, A, 1990)
"Neurocysticercosis is an infection of the brain by the larval stage of the pork tapeworm."	2.46	Anthelmintics for people with neurocysticercosis. ( Abba, K; Ramaratnam, S; Ranganathan, LN, 2010)
"Neurocysticercosis is an infection of the brain by the larval stage of the pork tapeworm."	2.46	Anthelmintics for people with neurocysticercosis. ( Abba, K; Ramaratnam, S; Ranganathan, LN, 2010)
"Schistosomal myelopathy tends to occur early after infection and is more likely to be symptomatic than cerebral schistosomiasis."	2.44	Neurological complications of Schistosoma infection. ( Carod-Artal, FJ, 2008)
" Bioavailability of the drug is markedly reduced when given jointly with antiepileptics or corticosteroids, specially carbamazepine, phenytoin or dexamethasone."	2.40	Pharmacokinetic optimisation of the treatment of neurocysticercosis. ( Jung, H; Sotelo, J, 1998)
"MR-tomography showed an internal hydrocephalus and multiple contrast enhancing parenchymal cysts."	2.40	[Neurocysticercosis. Current review of the literature based on a long-term study of 2 clinically distinct German cases]. ( Delcker, A; Häussermann, P; Koeppen, S; Wiegand, F, 1999)
"Treatment with praziquantel or albendazole has hastened the disappearance of the cysts on computed tomography and improved clinical symptoms."	2.38	Neurocysticercosis: neurologic, pathogenic, diagnostic and therapeutic aspects. ( Davis, LE; Kornfeld, M, 1991)
"Cerebral cysticercosis is being diagnosed with increasing frequency in children in the United States."	2.37	Intraparenchymal cerebral cysticercosis in children: diagnosis and treatment. ( Crawford, TO; Mitchell, WG, 1988)
"When she presented with further seizures 6 months later, attempts to arrange neuroimaging and specialist assessment were unsuccessful owing to restrictions on routine healthcare services during the SARS-CoV-2 nationwide lockdown."	1.62	Hydatid brain cyst: A delayed diagnosis in a rural setting during COVID-19. ( Brink, AJ; Da Fonseca, SP; Enslin, JMN; Nuttall, J; Opperman, CJ; Tootla, HD, 2021)
"The praziquantel treatment is selected firstly when the diagnosis was established."	1.40	[Diagnosis and treatment of cerebral schistosomiasis: a report of 166 cases]. ( Huang, X; Jin, WX; Wu, M; Xie, K; Zhu, F, 2014)
"Cerebral sparganosis is a severe parasitic infection caused by the larvae of Spirometra mansoni."	1.39	Cerebral sparganosis in mainland Chinese patients. ( Hong, D; Wan, H; Wu, Y; Xie, H; Xu, R; Zhu, M, 2013)
"Cerebral paragonimiasis can cause epilepsy, especially grand mal seizures."	1.39	Cerebral paragonimiasis: a retrospective analysis of 89 cases. ( Chen, J; Chen, Z; Cui, G; Feng, H; Hu, R; Lin, J; Meng, H; Pan, J; Wu, N; Zhu, G; Zou, Y, 2013)
"Neurocysticercosis was easy to misdiagnose."	1.35	Clinical analysis of 52 cases of neurocysticercosis. ( Chaoshuang, L; Xiaohong, W; Zhanlian, H; Zhiliang, G; Zhixin, Z, 2008)
"The definitive diagnosis was cerebellar schistosomiasis japonica."	1.35	Cerebellar schistosomiasis: a case report with clinical analysis. ( Lei, D; Mao, Q; Wan, H, 2009)
"In Japan neurocysticercosis is a rare disease."	1.31	[A case of neurocysticercosis presenting as focal seizure]. ( Higuchi, H; Kobayashi, N; Okada, T; Sugiyama, M; Teramoto, A; Yabe, Y, 2000)
"Forty-four cases of pulmonary paragonimiasis, two also with evidence of cerebral infection, were found in Sin Ho District in Northern Viet Nam."	1.30	Paragonimiasis in Sin Ho District, Lai Chau Province, Viet Nam. ( Ha, LD; Hoa, LT; Pao, TC; Phoung, CT; Phue, NC; Tuan, LM; Van, NT; Vien, CV, 1997)
"Paragonimiasis is a helminthic disease of carnivorous animals."	1.30	[Paragonimiasis]. ( Carré, JC; Houmdaophet, S, 1998)
"Cysticercosis is the most common parasitic disease affecting the central nervous system."	1.29	Subarachnoid neurocysticercosis with occlusion of the major intracranial arteries: case report. ( Levy, AS; Lillehei, KO; Rubinstein, D; Stears, JC, 1995)
"Cysticercosis is discussed as a possible differential diagnosis."	1.29	Meningeal irritation: possible manifestation of cerebral Echinococcus infestation. ( Bakke, SJ; Dietrichs, E; van Knapen, F, 1994)
"After medical treatment of neurocysticercosis, there is usually remission or marked improvement in the associated seizure disorder."	1.28	The course of seizures after treatment for cerebral cysticercosis. ( Sotelo, J; Vazquez, V, 1992)
"Cysticercosis is a parasitic disease endemic in several developing countries where people consume raw or insufficiently cooked pork."	1.28	You drive me crazy: a case report of acute psychosis and neurocysticercosis. ( Milette, PC; Shriqui, CL, 1992)
"Treatment with praziquantel resulted in the regression of only some of the cysts."	1.28	[Selective sensitivity of cysts to praziquantel and albendazole in a case of cerebral cysticercosis]. ( Belec, L; Cohen, L; Pierrot-Deseilligny, C; Sanson, M; Signoret, JL, 1992)
"Praziquantel was given orally at a dosage of 45 mg/kg/day in 3 divided doses at 4-5 hour interval for 15 days."	1.28	The treatment of neurocysticercosis with praziquantel. ( Bunnag, D; Riganti, M; Vanijanonta, S, 1991)
"Neurocysticercosis has not to our knowledge been previously reported to have presented with myoclonus."	1.28	Myoclonus: a manifestation of neurocysticercosis. ( Chowdhury, V; Gulati, P; Puri, V, 1991)
"Praziquantel (PZQ) was administered to the patients at their admission to the study."	1.28	[Neurocysticercosis and praziquantel: long-term development in 100 patients]. ( Livramento, JA; Machado, LR; Nóbrega, JP; Spina-França, A, 1989)
"Treatment with praziquantel was given at 35 mg/day for 10 days, dexamethasone and carbamazepine were also given to reduce side effects."	1.27	Subcutaneous and cerebral cysticercosis treated with praziquantel. ( Conde, J; Cross, JH; Quimosing, EM, 1984)
"Treatment with praziquantel 50 mg/kg body weight daily for 14 days resulted in clinical and radiological improvement in the first patient, although she obviously still harbored a number of viable non-calcified parasites."	1.27	Cerebral cysticercosis: treatment with praziquantel. Report of two cases. ( Hess, K; Markwalder, K; Valavanis, A; Witassek, F, 1984)
"By treatment with praziquantel there was an essential improvement of seizure frequency and headaches."	1.27	[Cerebral cysticercosis. A report on the treatment with praziquantel]. ( Maier-Metz, F; Meyer-Wahl, JG, 1984)
"Cysticercosis is the most common parasitosis affecting the central nervous system and it is endemic in many countries."	1.27	Brain cysticercosis treated with praziquantel. Report of six cases. ( Abad, JM; Bollar, A; Fernańdez, J; García-Allut, A; Gelabert, M; Mostaza, A, 1988)
"Cerebral cysticercosis was diagnosed with computed tomography (CT) scan, showing signs of intracranial hypertension and cystic lesions, and was confirmed by serological investigation."	1.27	Cerebral cysticercosis successfully treated with praziquantel. ( Braconier, JH; Christensson, B, 1988)
"Neurocysticercosis is not uncommon in the immigrant population of large North American cities."	1.27	Neurocysticercosis: surgical and medical management with praziquantel. ( Farmer, JP; Knowles, KF; Leblanc, R; MacLean, JD; Melanson, D; Rouleau, G, 1986)
"The use of praziquantel in the treatment of cysticercosis is a major step towards eradicating the disease, but to be effective treatment must take cognizance of reinfection, the allergic reaction caused by the dying parasites, and the possible need for repeated courses of treatment."	1.27	Neurocysticercosis--a comprehensive approach to medical treatment. ( Joubert, J; Joubert, MJ; Lombaard, CM, 1985)

Research

Studies (185)

Authors

Clinical Trials (3)

Trial Overview

Trial Outcomes

Phase III Trial - Proportion of Patients Without Remaining Live Cysts

Timeframe	Studies, this research(%)	All Research%
pre-1990	78 (42.16)	18.7374
1990's	80 (43.24)	18.2507
2000's	14 (7.57)	29.6817
2010's	10 (5.41)	24.3611
2020's	3 (1.62)	2.80

Authors	Studies
Opperman, CJ	1
Enslin, JMN	1
Nuttall, J	1
Brink, AJ	1
Da Fonseca, SP	1
Tootla, HD	1
Zhu, Y	1
Ye, L	1
Ding, X	1
Wu, J	1
Chen, Y	1
Ahmed, MMZ	1
Osman, HHM	1
Mohamed, AHA	1
Ginawi, A	1
Monk, EJM	1
Abba, K	3
Ranganathan, LN	3
Wei, Y	1
Huang, N	1
Chen, S	1
Chen, D	1
Li, X	1
Xu, J	1
Yang, Z	1
Yu-Hua, F	1
Ji-Guang, D	1
Hong, D	1
Xie, H	1
Zhu, M	1
Wan, H	2
Xu, R	1
Wu, Y	1
Zhu, F	1
Huang, X	1
Wu, M	1
Jin, WX	1
Xie, K	1
Garcia, HH	3
Lescano, AG	1
Gonzales, I	1
Bustos, JA	1
Pretell, EJ	2
Horton, J	2
Saavedra, H	2
Gonzalez, AE	1
Gilman, RH	2
Chaoshuang, L	1
Zhixin, Z	1
Xiaohong, W	1
Zhanlian, H	1
Zhiliang, G	1
Lei, D	1
Mao, Q	1
George, J	1
Rose, D	1
Hazrati, LN	1
Majl, L	1
Hodaie, M	1
Ramaratnam, S	2
Takayanagui, OM	3
Odashima, NS	1
Bonato, PS	1
Lima, JE	1
Lanchote, VL	1
Chen, J	1
Chen, Z	1
Lin, J	1
Zhu, G	1
Meng, H	1
Cui, G	1
Wu, N	1
Hu, R	1
Pan, J	1
Zou, Y	1
Feng, H	1
Al Shahrani, D	1
Frayha, HH	1
Dabbagh, O	1
Al Shail, E	1
Schweizer, G	1
Grünenfelder, F	1
Sydler, T	1
Rademacher, N	1
Braun, U	1
Deplazes, P	1
Roberts, M	1
Cross, J	1
Pohl, U	1
Lucas, S	1
Dean, A	1
Salinas, R	2
Prasad, K	2
Carod-Artal, FJ	1
Hayashi, M	1
Matsuda, H	1
Tormis, LC	1
Nosenas, JS	1
Blas, BL	1
Zhu, DY	2
Xu, WC	2
Qian, YD	2
Bao, YF	1
Qu, JQ	1
Grisolia, JS	1
Nash, TE	1
Neva, FA	1
Baas, H	1
Schneider, E	2
Grau, H	1
Prange, H	1
Gräfin Vitzthum, H	1
Ma, YX	1
Bell, DR	1
Colli, BO	1
Martelli, N	1
Assirati Júnior, JA	1
Machado, HR	1
Guerreiro, NE	1
Belluci, A	1
Biller, J	1
Azar-Kia, B	1
O'Keefe, P	1
Quimosing, EM	1
Conde, J	1
Cross, JH	2
Pun, KK	1
Wong, WT	1
Chen, WK	1
Lawner, PM	1
Sotelo, J	13
Escobedo, F	5
Rodriguez-Carbajal, J	3
Torres, B	3
Rubio-Donnadieu, F	3
Markwalder, K	1
Hess, K	1
Valavanis, A	1
Witassek, F	1
Meyer-Wahl, JG	1
Maier-Metz, F	1
deGhetaldi, LD	1
Norman, RM	2
Douville, AW	1
Lombardo, L	1
Vasconcelos, D	2
Cruz-Segura, H	2
Spina-França, A	3
Nóbrega, JP	3
Robles, C	3
Chavarría, M	1
Carpio, A	2
Santillán, F	1
León, P	1
Flores, C	1
Hauser, WA	2
Levy, AS	1
Lillehei, KO	1
Rubinstein, D	1
Stears, JC	1
Agarwal, AK	1
Dudeja, RK	1
Chandra, S	1
Dietrichs, E	1
van Knapen, F	1
Bakke, SJ	1
Diederich, C	1
Keuchel, M	1
Burchard, GD	1
Gilbert, P	1
Dietrich, M	1
Chagnon, A	2
Galzin, M	1
de Jaureguiberry, JP	1
Boyer, B	1
Paris, JF	2
Marlier, S	1
Carli, P	2
Rolfs, A	1
Mühlschlegel, F	1
Jansen-Rosseck, R	1
Martins, AR	1
Bedaque, EA	1
Tamburus, WM	1
Pedretti, L	1
Schulte, G	1
Feldmeier, H	1
Kremsner, P	1
Mafojane, NA	1
Pollner, JH	1
Schwartz, A	2
Kobrine, A	1
Parenti, DM	1
Shimamoto, Y	1
Sugiyama, E	1
Inaba, M	1
Shinoda, J	1
Shimazaki, K	1
Yamada, F	1
Flisser, A	3
Madrazo, I	3
Plancarte, A	3
Schantz, P	1
Allan, J	1
Craig, P	1
Sarti, E	1
Monteiro, L	1
Almeida-Pinto, J	1
Stocker, A	1
Sampaio-Silva, M	1
Dachman, WD	1
Adubofour, KO	1
Bikin, DS	1
Johnson, CH	1
Mullin, PD	1
Winograd, M	1
Dumois, JA	1
Whitman, BW	1
Vezina, LG	1
Shandera, WX	1
White, AC	1
Chen, JC	1
Diaz, P	1
Armstrong, R	1
Del Brutto, OH	4
Michel-Harder, C	1
Gubler, C	1
Rowedder, A	1
Schafroth, E	1
Schlup, P	1
Na-Bangchang, K	1
Vanijanonta, S	2
Karbwang, J	1
Corona, T	2
Lugo, R	1
Medina, R	1
Brouwer, RE	1
Thijssen, H	1
van der Meer, JW	1
Overbosch, D	1
Buitrago, M	1
Edwards, B	1
Rosner, F	1
Nagayama, M	1
Shinohara, Y	1
Nagakura, K	1
Izumi, Y	1
Takagi, S	1
Ostrosky-Wegman, P	1
Gonsebatt, ME	1
Sachdeva, RS	1
Manchanda, SK	1
Abrol, S	1
Wadhwa, SC	1
Ramachandran, KA	1
Paparone, PW	1
Menghetti, RA	1
Oka, Y	1
Fukui, K	1
Shoda, D	1
Abe, T	1
Kumon, Y	1
Sakaki, S	1
Torii, M	1
Bang, OY	1
Heo, JH	1
Choi, SA	1
Kim, DI	1
Alla, P	1
Del Giudice, P	1
Bernard, E	1
Perrin, C	1
Marty, P	2
Le Fichoux, Y	1
Ortonne, JP	1
Michiels, JF	1
Dellamonica, P	1
Aggarwal, SP	1
Sabharwal, BD	1
Proaño, JV	2
García, L	1
García-Torres, E	1
Correa, D	2
Jung, H	4
Vien, CV	1
Phue, NC	1
Ha, LD	1
Tuan, LM	1
Van, NT	1
Pao, TC	1
Hoa, LT	1
Phoung, CT	1
Escobar, A	1
Carré, JC	1
Houmdaophet, S	1
Wiegand, F	1
Koeppen, S	1
Häussermann, P	1
Delcker, A	1
Fowler, R	1
Lee, C	1
Keystone, JS	1
Tan, TY	1
Lui, CC	1
Chen, HJ	1
Liou, CW	1
Sugiyama, M	1
Okada, T	1
Higuchi, H	1
Yabe, Y	1
Kobayashi, N	1
Teramoto, A	1
Belo, M	1
Grunitzky, EK	1
Balogou, A	1
Kowu, L	1
Martinez, M	1
Avelar, F	1
López-Félix, B	1
Díaz, G	1
Grijalva, I	1
Lev, N	1
Michowiz, S	1
Inbar, E	1
Coire, CI	1
Pitlik, S	1
Melamed, E	1
Moses, PD	1
Kirubakaran, C	1
Chacko, DS	1
Bills, DC	1
Symon, L	1
Pejaver, RK	1
Bartolomei, F	1
Nicoli, F	1
Swiader, L	1
Gastaut, JL	1
Zhu, S	1
Vazquez, V	1
Jardim, E	1
Jena, A	1
Sanchetee, PC	1
Tripathi, R	1
Jain, RK	1
Gupta, AK	1
Sapra, ML	1
Torres, A	1
Villalobos, AN	1
de Aluja, AS	1
Navarro, R	1
Shriqui, CL	1
Milette, PC	1
Cohen, L	1
Belec, L	1
Sanson, M	1
Pierrot-Deseilligny, C	1
Signoret, JL	1
Vazquez, ML	2
Sanchez, M	2
Penagos, P	4
Puri, V	2
Sharma, DK	1
Kumar, S	1
Choudhury, V	1
Gupta, RK	1
Khalil, A	1
Cruz, M	1
Cruz, I	1
Bunnag, D	1
Riganti, M	1
de Queiroz, AC	1
Andrade Filho, Ade S	1
Allcut, DA	1
Coulthard, A	1
Davis, LE	1
Kornfeld, M	1
Jia, JY	1
Fernández-Rodríguez, R	1
Ozaita, G	1
Viso, A	1
García-Mata, R	1
Gómez, A	1
Fernández, O	1
Chong, MS	1
Hawkins, CP	1
Cook, GC	1
Hawkes, CH	1
Kocen, RS	1
Hagelskjaer, LH	1
Hansen, NJ	1
Christensen, T	1
Alarcón, F	1
Dueñas, G	1
Moncayo, J	1
Escalante, L	1
Chowdhury, V	1
Gulati, P	1
Mehndiratta, MM	1
Gupta, M	1
Machado, LR	2
Barros, NG	1
Livramento, JA	2
Bacheschi, LA	1
Jagota, SC	1
Bequet, D	1
Goasguen, J	1
Gonzalez, D	1
Ostrosky, P	1
Montero, R	1
Stephano, A	1
Joubert, J	3
Van As, AD	1
Heap, BJ	1
Verster, A	1
Tustin, RC	1
Hurtado, M	1
Medina, MT	1
Jenni, WK	1
Moodley, M	2
Gupta, R	1
Yadav, NV	1
Fleet, WF	1
Morgan, HJ	1
Lile, S	1
Rim, HJ	1
Joo, KH	1
Mao, SC	1
Ye, XC	1
Liu, JX	1
Zhang, JW	1
Richards, F	1
Sullivan, J	1
Ruiz-Tiben, E	1
Eberhard, M	1
Bishop, H	1
Moosa, A	1
Guerreiro, MM	1
Facure, NO	1
Guerreiro, CA	1
Misra, SC	1
Mansharamani, GG	1
King, CH	1
Mahmoud, AA	1
Estañol, B	1
Juárez, H	1
Irigoyen, Mdel C	1
González-Barranco, D	1
Rawlings, D	1
Ferriero, DM	1
Messing, RO	1
Pansey, BK	1
Basra, KS	1
Pasricha, R	1
Fandiño, J	1
Rodríguez, M	1
Pastor, A	1
Viladrich, A	1
Botana, C	1
Gómez-Bueno, J	1
Alvarez Sabin, J	1
Espinach, J	1
Boada, M	1
Codina Puiggros, A	1
Teitelbaum, GP	1
Otto, RJ	1
Lin, M	1
Watanabe, AT	1
Stull, MA	1
Manz, HJ	1
Bradley, WG	1
Watt, G	2
Adapon, B	1
Long, GW	1
Fernando, MT	1
Ranoa, CP	1
Yi, ZS	1
Quintero-Rodriguez, E	1
Abad, JM	1
Fernańdez, J	1
Bollar, A	1
Gelabert, M	1
Mostaza, A	1
García-Allut, A	1
Madhu, S	1
Sehra, D	1
Aggarwal, SK	1
Verma, NP	1
Nii, Y	1
Nakagawa, H	1
Taki, T	1
Nakabayashi, T	1
Parikh, PM	1
Anjaria, PD	1
Chile, VS	1
Van Linthoudt, D	1
Robert, CF	1
Ott, H	1
Gari-Toussaint, M	1
Lanteri-Minet, M	1
Barres, P	1

Trial	Phase	Enrollment	Study Type	Start Date	Status
Antiparasitic Therapy for Neurocysticercosis: Phase II/III Study on Safety and Efficacy of Combined Treatment With Praziquantel and Albendazole[NCT00441285]	Phase 2/Phase 3	156 participants (Actual)	Interventional	2010-01-31	Completed
Clinical, Laboratory and Imaging Features, Treatment Trends and Long Term Outcomes in Patients With Parenchymal and Extraparenchymal Neurocysticercosis-A Registry Based Study[NCT04706819]		1,000 participants (Anticipated)	Observational [Patient Registry]	2021-01-15	Not yet recruiting
Analysis of the Occurrence of Perilesional Edema and Seizures in Patients With Inactive Cysticercosis[NCT00001912]		6 participants (Actual)	Observational	1999-08-10	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Proportion of patients whose 6 month MR does not show viable parasites anymore (NCT00441285)
Timeframe: Day 180

PK Substudy - Area Under the Curve of Albendazole in Treatment Days 10 and 11

Intervention	participants (Number)
Phase III Trial - ABZ+PZQ	25
Phase III Trial - Increased ABZ	19
Phase III Trial - Standard ABZ	15

- To evaluate kinetic disposition of Albendazole we calculated the Area under the curve of the active metabolite of Albendazole (Albendazole Sulphoxide) with Praziquantel or Placebo (of Praziquantel). (NCT00441285)
Timeframe: 0.5, 1, 1.5, 2, 3, 4, 8, 10, 12, 24 and 36 hours post dose on Treatment days 10-11

PK Substudy - Area Under the Curve of Albendazole in Treatment in Day 1

Intervention	ng*h/ml (Mean)
Albendazole + Praziquantel	4925.3
Albendazole + Placebo	2969.6

- To evaluate kinetic disposition of Albendazole we calculated the Area under the curve of the active metabolite of Albendazole (Albendazole Sulphoxide) with Praziquantel or Placebo (of Praziquantel). (NCT00441285)
Timeframe: 0, 0.5, 1, 1.5, 2, 3, 4, 8, 10 and 12 hours post dose on Treatment day 1

PK Substudy - Area Under the Curve of Praziquantel by Antiepileptic Drug in Treatment Days 10 and 11

Intervention	ng*h/mL (Mean)
Albendazole + Praziquantel	1412.2
Albendazole + Placebo	1111

- To evaluate the kinetic disposition of Praziquantel by antiepileptic drug after the last praziquantel dose, we calculated the Area Under the Curve of Praziquantel with Carbamazepine or Phenytoin (NCT00441285)
Timeframe: 0.5, 1, 1.5, 2, 3, 4, 8, 10, 12, 24 and 36 hours post dose on treatment days 10-11

PK Substudy - Maximum Concentration of Albendazole

Intervention	ng*h/ml (Mean)
Carbamazepine	240.2
Phenytoin	550.1

Highest serum level of Albendazole measured from all level assessments in the curve. (NCT00441285)
Timeframe: Treatment day 1 and Treatment days 10-11

PK Substudy - Safety of Combined Albendazole Plus Praziquantel Therapy

Intervention	ng/mL (Mean)
Albendazole + Praziquantel	1293.9
Albendazole + Placebo	2232.8

- Describe if some Serious Adverse Event was associated to combined Albendazole plus Praziquantel therapy. (NCT00441285)
Timeframe: 90 days post tx

PK Substudy - Area Under the Curve of Praziquantel by Antiepileptic Drug in Treatment Day 1

Intervention	Events (Number)
Albendazole + Praziquantel	0
Albendazole + Placebo	0

- To evaluate the kinetic disposition of Praziquantel by antiepileptic drug after the last praziquantel dose, we calculated the Area Under the Curve of Praziquantel with Carbamazepine or Phenytoin (NCT00441285)
Timeframe: 0, 0.5, 1, 1.5, 2, 3, 4, 8, 10 and 12 hours post dose in treatment day 1

Intervention	ng*h / mL (Mean)
	Carbamazepine (n=8)	Phenytoin (n=8)
Albendazole + Praziquantel	548.3	923.7

Article	Year
Cerebral sparganosis presenting with atypical postcontrast magnetic resonance imaging findings: a case report and literature review. BMC infectious diseases, 2019, Aug-27, Volume: 19, Issue:1 Topics: Adult; Animals; Anthelmintics; Antibodies, Helminth; Brain Diseases; Cerebrospinal Fluid; Contrast M	2019
Surgical management outcome of cerebral schistosomiasis: a case report and review of the literature. Journal of medical case reports, 2021, May-23, Volume: 15, Issue:1 Topics: Adult; Brain Diseases; Humans; Male; Praziquantel; Schistosomiasis; Schistosomiasis mansoni; Sudan;	2021
Anthelmintics for people with neurocysticercosis. The Cochrane database of systematic reviews, 2021, 06-01, Volume: 6 Topics: Adult; Albendazole; Anticestodal Agents; Bias; Brain Diseases; Child; Humans; Neurocysticercosis; Pl	2021
Anthelmintics for people with neurocysticercosis. The Cochrane database of systematic reviews, 2010, Jan-20, Issue:1 Topics: Adult; Albendazole; Anticestodal Agents; Brain Diseases; Child; Humans; Neurocysticercosis; Praziqua	2010
Anthelmintics for people with neurocysticercosis. The Cochrane database of systematic reviews, 2010, Mar-17, Issue:3 Topics: Adrenal Cortex Hormones; Adult; Albendazole; Anticestodal Agents; Brain Diseases; Child; Humans; Neu	2010
Medical management of neurocysticercosis. Expert opinion on pharmacotherapy, 2011, Volume: 12, Issue:18 Topics: Albendazole; Animals; Anthelmintics; Brain Diseases; Humans; Life Cycle Stages; Magnetic Resonance I	2011
WITHDRAWN: Drugs for treating neurocysticercosis (tapeworm infection of the brain). The Cochrane database of systematic reviews, 2007, Jul-18, Issue:4 Topics: Albendazole; Anticestodal Agents; Brain Diseases; Humans; Neurocysticercosis; Praziquantel; Trichlor	2007
Neurological complications of Schistosoma infection. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2008, Volume: 102, Issue:2 Topics: Africa; Animals; Brain Diseases; Comorbidity; Diagnosis, Differential; Glucocorticoids; HIV Infectio	2008
Cysticercosis update. The Western journal of medicine, 1984, Volume: 140, Issue:6 Topics: Anticonvulsants; Brain Diseases; Cysticercosis; Humans; Isoquinolines; Praziquantel; Steroids	1984
Recent advances in the diagnosis and treatment of cerebral cysticercosis. The New England journal of medicine, 1984, Dec-06, Volume: 311, Issue:23 Topics: Brain Diseases; Cysticercosis; Humans; Hydrocephalus; Praziquantel; Prognosis; Serologic Tests; Taen	1984
Active neurocysticercosis, parenchymal and extraparenchymal: a study of 38 patients. Journal of neurology, 1993, Volume: 241, Issue:1 Topics: Adolescent; Adult; Albendazole; Animals; Antibodies, Helminth; Brain Diseases; Cerebrospinal Fluid S	1993
Distinctive serial magnetic resonance changes in a young woman with rapidly evolved neurocysticercosis, with positron emission tomography results. Journal of neuroimaging : official journal of the American Society of Neuroimaging, 1996, Volume: 6, Issue:3 Topics: Adult; Antiplatyhelmintic Agents; Brain; Brain Diseases; Cysticercosis; Deoxyglucose; Female; Fluori	1996
Cerebral cysticercosis manifesting as hydrocephalus--case report. Neurologia medico-chirurgica, 1996, Volume: 36, Issue:9 Topics: Aged; Animals; Antiplatyhelmintic Agents; Brain Diseases; Combined Modality Therapy; Cysticercosis;	1996
[Subcutaneous cysticercosis]. Annales de dermatologie et de venereologie, 1996, Volume: 123, Issue:8 Topics: Adult; Antiparasitic Agents; Antiplatyhelmintic Agents; Brain Diseases; Cysticercosis; Epilepsy; Hum	1996
Treatment of brain cysticercosis. Surgical neurology, 1997, Volume: 48, Issue:2 Topics: Albendazole; Anthelmintics; Anti-Inflammatory Agents; Brain Diseases; Cysticercosis; Dexamethasone;	1997
Pharmacokinetic optimisation of the treatment of neurocysticercosis. Clinical pharmacokinetics, 1998, Volume: 34, Issue:6 Topics: Absorption; Albendazole; Animals; Anthelmintics; Biological Availability; Brain Diseases; Cysticerco	1998
Cysticercosis and epilepsy: a critical review. Epilepsia, 1998, Volume: 39, Issue:10 Topics: Albendazole; Anthelmintics; Antiplatyhelmintic Agents; Brain; Brain Diseases; Clinical Trials as Top	1998
[Neurocysticercosis. Current review of the literature based on a long-term study of 2 clinically distinct German cases]. Der Nervenarzt, 1999, Volume: 70, Issue:4 Topics: Brain; Brain Diseases; Combined Modality Therapy; Cysticercosis; Follow-Up Studies; Humans; Hydrocep	1999
Drugs for treating neurocysticercosis (tapeworm infection of the brain). The Cochrane database of systematic reviews, 2000, Issue:2 Topics: Albendazole; Anticestodal Agents; Brain Diseases; Humans; Neurocysticercosis; Praziquantel; Trichlor	2000
Neurocysticercosis. The Israel Medical Association journal : IMAJ, 2002, Volume: 4, Issue:1 Topics: Anthelmintics; Brain; Brain Diseases; Female; Humans; Middle Aged; Neurocysticercosis; Praziquantel;	2002
Cerebral neurocysticercosis--case report and review. Journal of the Royal Society of Health, 1992, Volume: 112, Issue:4 Topics: Brain Diseases; Child; Cysticercosis; Humans; Male; Praziquantel	1992
Neurocysticercosis: neurologic, pathogenic, diagnostic and therapeutic aspects. European neurology, 1991, Volume: 31, Issue:4 Topics: Albendazole; Animals; Brain Diseases; Cysticercosis; Humans; Magnetic Resonance Imaging; Meninges; P	1991
Treatment of neurocysticercosis: is praziquantel the new hope? Lancet (London, England), 1989, Feb-04, Volume: 1, Issue:8632 Topics: Brain Diseases; Cysticercosis; Evaluation Studies as Topic; Humans; Praziquantel	1989
Drugs five years later: praziquantel. Annals of internal medicine, 1989, Feb-15, Volume: 110, Issue:4 Topics: Animals; Brain Diseases; Costs and Cost Analysis; Cysticercosis; Echinococcosis; Humans; Praziquante	1989
Intraparenchymal cerebral cysticercosis in children: diagnosis and treatment. Pediatrics, 1988, Volume: 82, Issue:1 Topics: Acute Disease; Adolescent; Adult; Animals; Black People; Brain Diseases; Calcinosis; Carbamazepine;	1988

Article	Year
Cysticidal Efficacy of Combined Treatment With Praziquantel and Albendazole for Parenchymal Brain Cysticercosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, 06-01, Volume: 62, Issue:11 Topics: Adolescent; Adult; Albendazole; Animals; Anticestodal Agents; Brain Diseases; Female; Humans; Male;	2016
Is the course of neurocysticercosis modified by treatment with antihelminthic agents? Archives of internal medicine, 1995, Oct-09, Volume: 155, Issue:18 Topics: Adult; Aged; Albendazole; Anthelmintics; Brain Diseases; Cysticercosis; Drug Therapy, Combination; F	1995
Plasma concentrations of praziquantel during the therapy of neurocysticerosis with praziquantel, in the presence of antiepileptics and dexamethasone. The Southeast Asian journal of tropical medicine and public health, 1995, Volume: 26, Issue:1 Topics: Adult; Anticonvulsants; Antiplatyhelmintic Agents; Biological Availability; Brain Diseases; Cysticer	1995
Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle. Journal of neurosurgery, 1997, Volume: 87, Issue:1 Topics: Adult; Albendazole; Anthelmintics; Antiplatyhelmintic Agents; Brain Diseases; Cerebral Ventricles; C	1997
Failure of one-day praziquantel treatment in patients with multiple neurocysticercosis lesions. Clinical neurology and neurosurgery, 2001, Volume: 103, Issue:3 Topics: Adult; Animals; Anthelmintics; Brain Diseases; Cysticercus; Female; Humans; Male; Middle Aged; Neuro	2001
Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. The New England journal of medicine, 2001, Sep-20, Volume: 345, Issue:12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Anticestodal Agents; Brain Diseases; Dexame	2001
Therapy for neurocysticercosis. Comparison between albendazole and praziquantel. Archives of neurology, 1992, Volume: 49, Issue:3 Topics: Adolescent; Adult; Albendazole; Brain Diseases; Cerebrospinal Fluid; Child; Child, Preschool; Cystic	1992
Clinical evaluation of albendazole and praziquantel in the treatment of cerebral cysticercosis. The Southeast Asian journal of tropical medicine and public health, 1991, Volume: 22 Suppl Topics: Adult; Albendazole; Brain; Brain Diseases; Cysticercosis; Electroencephalography; Female; Follow-Up	1991
Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. Journal of neurology, 1990, Volume: 237, Issue:2 Topics: Adolescent; Adult; Aged; Albendazole; Brain Diseases; Cysticercosis; Drug Administration Schedule; F	1990
[Neurocysticercosis. II. Evaluation of treatment with praziquantel]. Arquivos de neuro-psiquiatria, 1990, Volume: 48, Issue:1 Topics: Adolescent; Adult; Brain Diseases; Child; Child, Preschool; Clinical Trials as Topic; Cysticercosis;	1990
Treatment of cerebral coenuriosis in sheep with praziquantel. Journal of the South African Veterinary Association, 1990, Volume: 61, Issue:1 Topics: Acute Disease; Animals; Brain Diseases; Chronic Disease; Pilot Projects; Praziquantel; Sheep; Sheep	1990

Article	Year
Hydatid brain cyst: A delayed diagnosis in a rural setting during COVID-19. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2021, 11-05, Volume: 111, Issue:11 Topics: Albendazole; Anticestodal Agents; Brain Diseases; Child; COVID-19; Delayed Diagnosis; Echinococcosis	2021
The diagnosis and treatment introspection of the first imported case of atypical cerebral schistosomiasis in Guangzhou city. PLoS neglected tropical diseases, 2018, Volume: 12, Issue:3 Topics: Aged; Brain Diseases; China; Female; Humans; Magnetic Resonance Imaging; Occipital Lobe; Praziquante	2018
[Treatment and nursing of a cysticercosis patient with multiple foci]. Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control, 2018, Feb-10, Volume: 30, Issue:2 Topics: Animals; Antiparasitic Agents; Brain Diseases; Cysticercosis; Diet; Humans; Male; Praziquantel; Red	2018
Cerebral sparganosis in mainland Chinese patients. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2013, Volume: 20, Issue:11 Topics: Adolescent; Adult; Anthelmintics; Brain Diseases; Child; China; Female; Humans; Male; Middle Aged; N	2013
[Diagnosis and treatment of cerebral schistosomiasis: a report of 166 cases]. Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control, 2014, Volume: 26, Issue:6 Topics: Adult; Aged; Anthelmintics; Brain Diseases; Female; Humans; Male; Middle Aged; Neuroschistosomiasis;	2014
Clinical analysis of 52 cases of neurocysticercosis. Tropical doctor, 2008, Volume: 38, Issue:3 Topics: Adolescent; Adult; Albendazole; Anthelmintics; Brain; Brain Diseases; Child; China; Female; Humans;	2008
Cerebellar schistosomiasis: a case report with clinical analysis. The Korean journal of parasitology, 2009, Volume: 47, Issue:1 Topics: Adrenal Cortex Hormones; Animals; Brain Diseases; Cerebellum; Humans; Magnetic Resonance Imaging; Ma	2009
Cerebral schistosomiasis--an unusual presentation of an intracranial mass lesion. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2009, Volume: 36, Issue:2 Topics: Adult; Animals; Anthelmintics; Anti-Inflammatory Agents; Anticonvulsants; Antitubercular Agents; Bra	2009
Cerebral paragonimiasis: a retrospective analysis of 89 cases. Clinical neurology and neurosurgery, 2013, Volume: 115, Issue:5 Topics: Adolescent; Adult; Antiplatyhelmintic Agents; Brain; Brain Diseases; Brain Edema; Cerebral Angiograp	2013
First case of neurocysticercosis in Saudi Arabia. Journal of tropical pediatrics, 2003, Volume: 49, Issue:1 Topics: Brain Diseases; Female; Humans; Infant; Neurocysticercosis; Praziquantel; Saudi Arabia	2003
[Imported coenurosis in sheep]. Schweizer Archiv fur Tierheilkunde, 2006, Volume: 148, Issue:9 Topics: Animals; Anthelmintics; Benzimidazoles; Brain; Brain Diseases; Cestode Infections; Cysticercosis; Di	2006
Cerebral schistosomiasis. The Lancet. Infectious diseases, 2006, Volume: 6, Issue:12 Topics: Adult; Anthelmintics; Brain Diseases; Carbamazepine; Humans; Magnetic Resonance Imaging; Male; Neuro	2006
Clinical study on cerebral schistosomiasis japonica on Leyte Island, Philippines: follow-up study 6 years after treatment with antischistosomal drugs. The Southeast Asian journal of tropical medicine and public health, 1984, Volume: 15, Issue:4 Topics: Adult; Anticonvulsants; Benzenesulfonates; Brain Diseases; Drug Therapy, Combination; Female; Humans	1984
[Subclinical cerebral cysticercosis and Biltricide (praziquantel)]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 1984, Volume: 6, Issue:4 Topics: Adult; Brain Diseases; Cysticercosis; Female; Humans; Isoquinolines; Male; Middle Aged; Praziquantel	1984
[Cerebral cysticercosis. Diagnostic findings and new therapeutic possibilities]. Der Nervenarzt, 1983, Volume: 54, Issue:10 Topics: Adult; Aged; Brain Diseases; Cysticercosis; Diagnosis, Differential; Drug Therapy, Combination; Epil	1983
[A clinical study on the treatment of cerebral cysticercosis with praziquantel]. Zhonghua yi xue za zhi, 1984, Volume: 64, Issue:2 Topics: Adolescent; Adult; Brain Diseases; Child; Cysticercosis; Female; Humans; Intracranial Pressure; Isoq	1984
Cysticercosis: a new hope. British medical journal (Clinical research ed.), 1984, Oct-06, Volume: 289, Issue:6449 Topics: Adult; Brain Diseases; Cysticercosis; Humans; Isoquinolines; Praziquantel	1984
[Tumor form of neurocysticercosis: surgical removal of a cysticercus measuring 70X77 mm and treatment with praziquantel]. Arquivos de neuro-psiquiatria, 1984, Volume: 42, Issue:2 Topics: Adult; Brain Diseases; Brain Neoplasms; Cysticercosis; Diagnosis, Differential; Female; Humans; Isoq	1984
Praziquantel for cysticercosis of the brain parenchyma. The New England journal of medicine, 1984, Sep-13, Volume: 311, Issue:11 Topics: Brain Diseases; Cysticercosis; Humans; Isoquinolines; Praziquantel	1984
Cysticercosis and praziquantel therapy. Neurology, 1984, Volume: 34, Issue:12 Topics: Adult; Brain Diseases; Cysticercosis; Humans; Isoquinolines; Male; Praziquantel	1984
Subcutaneous and cerebral cysticercosis treated with praziquantel. The Southeast Asian journal of tropical medicine and public health, 1984, Volume: 15, Issue:2 Topics: Adult; Antibodies; Antiparasitic Agents; Brain Diseases; Cysticercosis; Cysticercus; Female; Hemaggl	1984
Successful treatment of neurocysticercosis with low-dose praziquantel. Tropical and geographical medicine, 1984, Volume: 36, Issue:3 Topics: Brain Diseases; Cysticercosis; Female; Humans; Isoquinolines; Middle Aged; Praziquantel	1984
Cerebral cysticercosis. Treatment with praziquantil. The Central African journal of medicine, 1984, Volume: 30, Issue:9 Topics: Brain Diseases; Cysticercosis; Female; Humans; Isoquinolines; Praziquantel	1984
[Effect of praziquantel in the treatment of 111 cases of cerebral cysticercosis cellulosae]. Zhonghua nei ke za zhi, 1984, Volume: 23, Issue:9 Topics: Adult; Aged; Brain; Brain Diseases; Cysticercosis; Female; Humans; Isoquinolines; Male; Middle Aged;	1984
Medical management of neurocysticercosis with Praziquantel. Bulletin of clinical neurosciences, 1983, Volume: 48 Topics: Brain Diseases; Cysticercosis; Humans; Isoquinolines; Kinetics; Praziquantel	1983
Therapy of parenchymal brain cysticercosis with praziquantel. The New England journal of medicine, 1984, Apr-19, Volume: 310, Issue:16 Topics: Adolescent; Adult; Brain; Brain Diseases; Cysticercosis; Drug Evaluation; Female; Follow-Up Studies;	1984
Cerebral cysticercosis: treatment with praziquantel. Report of two cases. The American journal of tropical medicine and hygiene, 1984, Volume: 33, Issue:2 Topics: Adult; Antibodies; Brain; Brain Diseases; Cysticercosis; Cysticercus; Dexamethasone; Drug Therapy, C	1984
[Cerebral cysticercosis. A report on the treatment with praziquantel]. Fortschritte der Medizin, 1984, Mar-29, Volume: 102, Issue:12 Topics: Antibodies; Brain Diseases; Cysticercosis; Cysticercus; Hemagglutination Tests; Humans; Isoquinoline	1984
Cerebral cysticercosis treated biphasically with dexamethasone and praziquantel. Annals of internal medicine, 1983, Volume: 99, Issue:2 Topics: Adult; Brain Diseases; Cysticercosis; Dexamethasone; Female; Humans; Isoquinolines; Praziquantel; To	1983
[Treatment of cysticercosis using praziquantel. Preliminary report of 10 cases]. Gaceta medica de Mexico, 1983, Volume: 119, Issue:1 Topics: Adult; Brain Diseases; Cysticercosis; Humans; Isoquinolines; Praziquantel; Tomography, X-Ray Compute	1983
[Neurocysticercosis and praziquantel. II. Evaluation of results in 20 patients]. Arquivos de neuro-psiquiatria, 1981, Volume: 39, Issue:3 Topics: Adrenal Cortex Hormones; Brain Diseases; Cysticercosis; Drug Interactions; Humans; Isoquinolines; Pr	1981
[Medical treatment of cerebral cysticercosis]. Gaceta medica de Mexico, 1981, Volume: 117, Issue:9 Topics: Adult; Brain Diseases; Child; Cysticercosis; Female; Humans; Isoquinolines; Male; Praziquantel; Tomo	1981
[A case of successfully treated cerebral cysticercosis]. Gaceta medica de Mexico, 1980, Volume: 116, Issue:2 Topics: Brain Diseases; Child; Cysticercosis; Humans; Isoquinolines; Male; Praziquantel; Tomography, X-Ray C	1980
Subarachnoid neurocysticercosis with occlusion of the major intracranial arteries: case report. Neurosurgery, 1995, Volume: 36, Issue:1 Topics: Brain Diseases; Carotid Stenosis; Cerebral Angiography; Cerebral Infarction; Combined Modality Thera	1995
Advances in treatment of neurocysticercosis. The Journal of the Association of Physicians of India, 1994, Volume: 42, Issue:1 Topics: Albendazole; Brain Diseases; Controlled Clinical Trials as Topic; Cysticercosis; Drug Administration	1994
Meningeal irritation: possible manifestation of cerebral Echinococcus infestation. Scandinavian journal of infectious diseases, 1994, Volume: 26, Issue:5 Topics: Adult; Animals; Antibodies, Helminth; Brain Diseases; Cysticercosis; Diagnosis, Differential; Echino	1994
[27-year-old patient with nodules in the breast, tongue, subcutis and brain]. Der Internist, 1994, Volume: 35, Issue:12 Topics: Adult; Brain; Brain Diseases; Breast; Breast Diseases; Cysticercosis; Dexamethasone; Drug Therapy, C	1994
[Prolonged treatment of recurrent neurocysticercosis using sequential doses of albendazole and praziquantel]. Medecine tropicale : revue du Corps de sante colonial, 1994, Volume: 54, Issue:3 Topics: Adult; Albendazole; Brain Diseases; Cysticercosis; Drug Administration Schedule; Drug Therapy, Combi	1994
Clinical and immunologic follow-up study of patients with neurocysticercosis after treatment with praziquantel. Neurology, 1995, Volume: 45, Issue:3 Pt 1 Topics: Adolescent; Adult; Antibodies, Helminth; Biopterins; Brain Diseases; Child; Cysticercosis; Enzyme-Li	1995
The neurocysticercosis project in Atteridgeville-Mamelodi townships. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1994, Volume: 84, Issue:4 Topics: Adolescent; Adult; Brain Diseases; Child; Cysticercosis; Female; Humans; Incidence; Male; Middle Age	1994
Cerebral schistosomiasis caused by Schistosoma haematobium: case report. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 18, Issue:3 Topics: Adult; Brain Diseases; Dexamethasone; Drug Therapy, Combination; Fresh Water; Humans; Malawi; Male;	1994
[Cerebral cysticercosis treated with praziquantel--a case report]. No to shinkei = Brain and nerve, 1994, Volume: 46, Issue:4 Topics: Adult; Brain Diseases; Cysticercosis; Drug Administration Schedule; Humans; Male; Praziquantel	1994
Neurological symptoms in occult neurocysticercosis after single taeniacidal dose of praziquantel. Lancet (London, England), 1993, Sep-18, Volume: 342, Issue:8873 Topics: Brain Diseases; Child; Cysticercosis; Female; Headache; Humans; Intestinal Diseases, Parasitic; Praz	1993
Cimetidine-induced rise in praziquantel levels in a patient with neurocysticercosis being treated with anticonvulsants. The Journal of infectious diseases, 1994, Volume: 169, Issue:3 Topics: Adult; Anticonvulsants; Brain Diseases; Cimetidine; Cysticercosis; Drug Therapy, Combination; Humans	1994
Profuse neurocysticercosis with minimal signs and a favorable outcome. The Pediatric infectious disease journal, 1993, Volume: 12, Issue:10 Topics: Brain; Brain Diseases; Child, Preschool; Cysticercosis; Dexamethasone; Drug Therapy, Combination; Fe	1993
Neurocysticercosis in Houston, Texas. A report of 112 cases. Medicine, 1994, Volume: 73, Issue:1 Topics: Adolescent; Adult; Animals; Brain Diseases; Child; Cysticercosis; Female; Humans; Male; Middle Aged;	1994
Case 8-1993: cysticercosis. The New England journal of medicine, 1993, Sep-09, Volume: 329, Issue:11 Topics: Albendazole; Brain Diseases; Cysticercosis; Humans; Praziquantel; Subarachnoid Space	1993
[A case from practice (272)--cerebral cysticercosis (neurocysticercosis)--infection with larvae of Taenia solium, swine tapeworm]. Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1993, Jul-20, Volume: 82, Issue:29-30 Topics: Adult; Animals; Brain Diseases; Cysticercosis; Female; Humans; Praziquantel; Pregnancy; Pregnancy Co	1993
[Grand-mal epilepsy as initial manifestation of a parenchymal neuro_cysticercosis]. Schweizerische medizinische Wochenschrift, 1993, Jan-30, Volume: 123, Issue:4 Topics: Adult; Animals; Antibodies, Helminth; Brain Diseases; Cysticercosis; Cysticercus; Enzyme-Linked Immu	1993
Single-day praziquantel therapy for neurocysticercosis. The New England journal of medicine, 1996, Jan-11, Volume: 334, Issue:2 Topics: Adult; Antiplatyhelmintic Agents; Brain Diseases; Cysticercosis; Drug Administration Schedule; Femal	1996
[2 patients with neurocysticercosis]. Nederlands tijdschrift voor geneeskunde, 1995, Dec-30, Volume: 139, Issue:52 Topics: Adult; Anthelmintics; Brain Diseases; Brain Neoplasms; Cysticercosis; Diagnosis, Differential; Epile	1995
Neurocysticercosis: Report of fifteen cases. The Mount Sinai journal of medicine, New York, 1995, Volume: 62, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiplatyhelmintic Agents; Brain Diseases; Child; Cystic	1995
Environmental toxicants in developing countries. Environmental health perspectives, 1996, Volume: 104 Suppl 3 Topics: Animal Population Groups; Animals; Antiparasitic Agents; Brain Diseases; Carcinogens; Chromosome Abe	1996
Freely mobile cysticercus in the anterior chamber. Indian journal of ophthalmology, 1995, Volume: 43, Issue:3 Topics: Adult; Animals; Anterior Chamber; Anti-Inflammatory Agents; Anticonvulsants; Antiplatyhelmintic Agen	1995
Case report: neurocysticercosis in pregnancy. New Jersey medicine : the journal of the Medical Society of New Jersey, 1996, Volume: 93, Issue:2 Topics: Adolescent; Anticonvulsants; Antiplatyhelmintic Agents; Brain Diseases; Cysticercosis; Epilepsy, Ton	1996
Large cerebral infarction during praziquantel therapy in neurocysticercosis. Stroke, 1997, Volume: 28, Issue:1 Topics: Antiplatyhelmintic Agents; Basal Ganglia; Brain Diseases; Carotid Artery, Internal; Cerebral Angiogr	1997
[Results of sequential prolonged courses of albendazole and praziquantel in recurrent neurocysticercosis]. Medecine tropicale : revue du Corps de sante colonial, 1996, Volume: 56, Issue:3 Topics: Adult; Albendazole; Anthelmintics; Brain Diseases; Cysticercosis; Drug Therapy, Combination; Humans;	1996
Praziquantel therapy in neurocysticercosis. The Journal of the Association of Physicians of India, 1995, Volume: 43, Issue:5 Topics: Adult; Antiplatyhelmintic Agents; Biopsy; Brain Diseases; Cysticercosis; Humans; Male; Middle Aged;	1995
Paragonimiasis in Sin Ho District, Lai Chau Province, Viet Nam. The Southeast Asian journal of tropical medicine and public health, 1997, Volume: 28 Suppl 1 Topics: Adolescent; Adult; Animals; Antiplatyhelmintic Agents; Brain Diseases; Child; Child, Preschool; Dog	1997
[Paragonimiasis]. Revue de pneumologie clinique, 1998, Volume: 54, Issue:6 Topics: Anthelmintics; Bithionol; Brain Diseases; Diagnosis, Differential; Female; Hemoptysis; Humans; Lung	1998
The role of corticosteroids in the treatment of cerebral schistosomiasis caused by Schistosoma mansoni: case report and discussion. The American journal of tropical medicine and hygiene, 1999, Volume: 61, Issue:1 Topics: Adult; Animals; Anti-Inflammatory Agents; Biopsy; Brain Diseases; Brazil; Dexamethasone; Headache; H	1999
Cerebral sparganosis: case report. Changgeng yi xue za zhi, 1999, Volume: 22, Issue:2 Topics: Adult; Brain Diseases; Humans; Magnetic Resonance Imaging; Male; Praziquantel; Sparganosis; Tomograp	1999
Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers. The Cysticercosis Working Group in Perú. Neurology, 1999, Oct-22, Volume: 53, Issue:7 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Albendazole; Animals; Anthelmintics; Brain Diseases; Car	1999
[A case of neurocysticercosis presenting as focal seizure]. No shinkei geka. Neurological surgery, 2000, Volume: 28, Issue:9 Topics: Adult; Albendazole; Anthelmintics; Brain Diseases; Combined Modality Therapy; Humans; Male; Neurocys	2000
[Cerebral cysticercosis and headache in a young Togolese woman]. Revue neurologique, 2001, Volume: 157, Issue:4 Topics: Adult; Anthelmintics; Brain Diseases; Female; France; Headache; Humans; Neurocysticercosis; Praziqua	2001
Disappearing CT lesions in focal seizures. Annals of tropical paediatrics, 1992, Volume: 12, Issue:3 Topics: Brain Diseases; Child; Cysticercosis; Epilepsies, Partial; Female; Humans; Phenytoin; Praziquantel;	1992
Cysticercosis producing various neurological presentations in a patient: case report. British journal of neurosurgery, 1992, Volume: 6, Issue:4 Topics: Adult; Brain Diseases; Combined Modality Therapy; Cysticercosis; Dexamethasone; Female; Follow-Up St	1992
[Value of experimental use of praziquantel in cases of isolated cerebral cysticercosis and follow-up of the evolution by MRI]. Annales de medecine interne, 1992, Volume: 143, Issue:4 Topics: Adolescent; Brain Diseases; Cysticercosis; Female; Follow-Up Studies; Humans; Magnetic Resonance Ima	1992
[A follow-up study of 420 cases of cerebral cysticercosis]. Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry, 1992, Volume: 25, Issue:4 Topics: Adolescent; Adult; Aged; Brain Diseases; Child; Child, Preschool; Cysticercosis; Dexamethasone; Fema	1992
The course of seizures after treatment for cerebral cysticercosis. The New England journal of medicine, 1992, Sep-03, Volume: 327, Issue:10 Topics: Adult; Albendazole; Brain; Brain Diseases; Cysticercosis; Epilepsy; Female; Follow-Up Studies; Human	1992
MR observations on the effects of praziquantel in neurocysticercosis. Magnetic resonance imaging, 1992, Volume: 10, Issue:1 Topics: Adult; Brain; Brain Diseases; Cysticercosis; Female; Humans; Magnetic Resonance Imaging; Male; Prazi	1992
Praziquantel treatment of porcine brain and muscle Taenia solium cysticercosis. 3. Effect of 1-day treatment. Parasitology research, 1992, Volume: 78, Issue:2 Topics: Animals; Antibodies, Helminth; Brain; Brain Diseases; Cysticercosis; Cysticercus; Enzyme-Linked Immu	1992
You drive me crazy: a case report of acute psychosis and neurocysticercosis. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1992, Volume: 37, Issue:2 Topics: Acute Disease; Adult; Brain Diseases; Cysticercosis; Dexamethasone; Electroencephalography; Female;	1992
[Selective sensitivity of cysts to praziquantel and albendazole in a case of cerebral cysticercosis]. Revue neurologique, 1992, Volume: 148, Issue:1 Topics: Adult; Albendazole; Brain Diseases; Cysticercosis; Drug Resistance; Drug Therapy, Combination; Follo	1992
Clinical pharmacokinetics of praziquantel. Proceedings of the Western Pharmacology Society, 1991, Volume: 34 Topics: Adult; Brain Diseases; Chromatography, High Pressure Liquid; Cysticercosis; Female; Humans; Male; Mi	1991
Neurocysticercosis in children. Indian pediatrics, 1991, Volume: 28, Issue:11 Topics: Adolescent; Albendazole; Brain Diseases; Child; Child, Preschool; Cysticercosis; Drug Therapy, Combi	1991
The treatment of neurocysticercosis with praziquantel. The Southeast Asian journal of tropical medicine and public health, 1991, Volume: 22 Suppl Topics: Adult; Brain; Brain Diseases; Cysticercosis; Female; Follow-Up Studies; Humans; Intracranial Pressur	1991
[Neurocysticercosis: neuropathologic study of a fatal case treated with praziquantel]. Arquivos de neuro-psiquiatria, 1991, Volume: 49, Issue:1 Topics: Adolescent; Brain Diseases; Cysticercosis; Humans; Male; Praziquantel	1991
Neurocysticercosis: regression of a fourth ventricular cyst with praziquantel. Journal of neurology, neurosurgery, and psychiatry, 1991, Volume: 54, Issue:5 Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Brain Diseases; Cerebral Ventricles; Cysticerc	1991
[Determination of praziquantel levels in cerebrospinal fluid and plasma in patients with cysticercosis of the central nervous system treated with praziquantel]. Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry, 1991, Volume: 24, Issue:3 Topics: Adult; Brain Diseases; Chromatography, High Pressure Liquid; Cysticercosis; Female; Humans; Male; Mi	1991
[Active and inactive forms of cerebral cysticercosis. Study of 10 cases]. Revista clinica espanola, 1991, Volume: 188, Issue:8 Topics: Adolescent; Aged; Brain Diseases; Child; Cysticercosis; Female; Humans; Male; Middle Aged; Praziquan	1991
A resistant case of neurocystercercosis. Postgraduate medical journal, 1991, Volume: 67, Issue:788 Topics: Adult; Albendazole; Brain Diseases; Cysticercosis; Drug Resistance; Drug Therapy, Combination; Femal	1991
[Cerebral cysticercosis]. Ugeskrift for laeger, 1991, Sep-23, Volume: 153, Issue:39 Topics: Adult; Brain Diseases; Cysticercosis; Female; Humans; Magnetic Resonance Imaging; Malaysia; Praziqua	1991
Neurocysticercosis. Neurology, 1991, Volume: 41, Issue:3 Topics: Anticonvulsants; Brain Diseases; Cysticercosis; Humans; Praziquantel; Tomography, X-Ray Computed	1991
Myoclonus: a manifestation of neurocysticercosis. Postgraduate medical journal, 1991, Volume: 67, Issue:783 Topics: Brain Diseases; Child; Cysticercosis; Female; Humans; Myoclonus; Praziquantel; Valproic Acid	1991
Neurocysticercosis. The Journal of the Association of Physicians of India, 1990, Volume: 38, Issue:11 Topics: Albendazole; Brain Diseases; Cysticercosis; Humans; Praziquantel	1990
Computed tomography in neurocysticercosis: a 10-year long evolution analysis of 100 patients with an appraisal of a new classification. Arquivos de neuro-psiquiatria, 1990, Volume: 48, Issue:4 Topics: Brain Diseases; Cysticercosis; Humans; Praziquantel; Prognosis; Retrospective Studies; Tomography, X	1990
Neurocysticercosis. The Journal of the Association of Physicians of India, 1990, Volume: 38, Issue:11 Topics: Albendazole; Brain Diseases; Cysticercosis; Drug Administration Schedule; Humans; Praziquantel	1990
[Medical treatment of cysticercosis and monitoring of disease course using magnetic resonance imaging]. Bulletin de la Societe de pathologie exotique (1990), 1990, Volume: 83, Issue:2 Topics: Adult; Brain Diseases; Cysticercosis; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging;	1990
Praziquantel treatment of brain and muscle porcine Taenia solium cysticercosis. 2. Immunological and cytogenetic studies. Parasitology research, 1990, Volume: 76, Issue:7 Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Brain Diseases; Chromosomes; Cysticercosis; Cysti	1990
Rapid and complete resolution of giant cysticercal cysts after administration of praziquantel. A report of 4 cases. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1990, Feb-03, Volume: 77, Issue:3 Topics: Adult; Brain Diseases; Cerebral Ventriculography; Cysticercosis; Female; Humans; Male; Middle Aged;	1990
Cerebral cysticercosis as a common cause of epilepsy in Gurkhas in Hong Kong. Journal of the Royal Army Medical Corps, 1990, Volume: 136, Issue:3 Topics: Adult; Brain Diseases; Cysticercosis; Enzyme-Linked Immunosorbent Assay; Epilepsy; Hong Kong; Humans	1990
Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosis. Clinical neuropharmacology, 1990, Volume: 13, Issue:6 Topics: Adolescent; Adult; Age Factors; Aged; Albendazole; Brain Diseases; Child; Cysticercosis; Female; Hum	1990
Treatment of neurocysticercosis. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1990, Jan-06, Volume: 77, Issue:1 Topics: Adult; Brain Diseases; Cysticercosis; Drug Therapy, Combination; Female; Humans; Male; Middle Aged;	1990
Treatment of neurocysticercosis with praziquantel. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1990, Aug-04, Volume: 78, Issue:3 Topics: Brain Diseases; Cysticercosis; Humans; Praziquantel	1990
Failure of praziquantel and albendazole in neurocysticercosis. The Journal of the Association of Physicians of India, 1990, Volume: 38, Issue:4 Topics: Adult; Albendazole; Brain Diseases; Cysticercosis; Drug Therapy, Combination; Follow-Up Studies; Hum	1990
Cystic brain lesions in a Haitian man. Journal of the Tennessee Medical Association, 1990, Volume: 83, Issue:8 Topics: Adult; Anticestodal Agents; Brain Diseases; Cysticercosis; Diagnosis, Differential; Haiti; Humans; M	1990
Clinical evaluation of the therapeutic efficacy of praziquantel against human cysticercosis. Acta Leidensia, 1989, Volume: 57, Issue:2 Topics: Adult; Antiparasitic Agents; Brain Diseases; Cysticercosis; Drug Tolerance; Female; Humans; Male; Mi	1989
[CT brain scanning in the diagnosis and localisation of cerebral schistosomiasis]. Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases, 1989, Volume: 7, Issue:2 Topics: Adolescent; Adult; Brain; Brain Diseases; Child; Female; Granuloma; Humans; Male; Middle Aged; Prazi	1989
Effect of praziquantel on the eggs of Schistosoma mansoni, with a note on the implications for managing central nervous system schistosomiasis. Annals of tropical medicine and parasitology, 1989, Volume: 83, Issue:5 Topics: Animals; Brain Diseases; Feces; Mice; Ovum; Parasite Egg Count; Praziquantel; Schistosoma mansoni; S	1989
Praziquantel for neurocysticercosis. Lancet (London, England), 1989, Apr-22, Volume: 1, Issue:8643 Topics: Adolescent; Adult; Brain Diseases; Child; Cysticercosis; Humans; Praziquantel	1989
[Cranial computed tomography aspects in neurocysticercosis in childhood]. Arquivos de neuro-psiquiatria, 1989, Volume: 47, Issue:2 Topics: Brain Diseases; Child; Cysticercosis; Diagnosis, Differential; Female; Humans; Male; Praziquantel; T	1989
Reply from authors. Praziquantel in neurocysticercosis. The Journal of the Association of Physicians of India, 1989, Volume: 37, Issue:5 Topics: Brain Diseases; Cysticercosis; Dexamethasone; Drug Combinations; Humans; Praziquantel	1989
[Neurocysticercosis and praziquantel: long-term development in 100 patients]. Arquivos de neuro-psiquiatria, 1989, Volume: 47, Issue:4 Topics: Adolescent; Adult; Aged; Brain Diseases; Child; Child, Preschool; Cysticercosis; Epilepsy; Female; F	1989
Humoral immune response in patients with cerebral parenchymal cysticercosis treated with praziquantel. Journal of neurology, neurosurgery, and psychiatry, 1989, Volume: 52, Issue:2 Topics: Adult; Animals; Antibody Formation; Antigen-Antibody Complex; Brain Diseases; Complement C3; Complem	1989
Early CT reevaluation after empiric praziquantel therapy in neurocysticercosis. Neurology, 1989, Volume: 39, Issue:5 Topics: Brain; Brain Diseases; Child; Cysticercosis; Female; Humans; Praziquantel; Tomography, X-Ray Compute	1989
Medically treated neurocysticercosis in a blind child. A case report. Surgical neurology, 1989, Volume: 32, Issue:1 Topics: Blindness; Brain Diseases; Child, Preschool; Cysticercosis; Female; Headache; Humans; Praziquantel;	1989
[Cerebral cysticercosis. 10 cases]. Revue neurologique, 1989, Volume: 145, Issue:5 Topics: Adult; Aged; Brain Diseases; Cerebrospinal Fluid Shunts; Cysticercosis; Female; Humans; Magnetic Res	1989
[Remission of a case of intraparenchymal neurocysticercosis following treatment with praziquantel]. Revista clinica espanola, 1989, Volume: 184, Issue:7 Topics: Brain Diseases; Cysticercosis; Humans; Male; Middle Aged; Praziquantel	1989
MR imaging of neurocysticercosis. AJR. American journal of roentgenology, 1989, Volume: 153, Issue:4 Topics: Adolescent; Adult; Aged; Brain; Brain Diseases; Child; Cysticercosis; Female; Humans; Magnetic Reson	1989
Praziquantel in treatment of cerebral schistosomiasis. Lancet (London, England), 1986, Sep-06, Volume: 2, Issue:8506 Topics: Adult; Brain Diseases; Brain Edema; Drug Evaluation; Female; Follow-Up Studies; Humans; Male; Middle	1986
[Clinical analysis and follow-up study of 92 cases of cerebral schistosomiasis]. Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry, 1988, Volume: 21, Issue:3 Topics: Adolescent; Adult; Brain Diseases; Brain Neoplasms; Child; Epilepsy; Female; Follow-Up Studies; Huma	1988
Praziquantel vs. albendazol for cysticercosis. Neurosurgery, 1988, Volume: 23, Issue:1 Topics: Albendazole; Anthelmintics; Benzimidazoles; Brain Diseases; Cysticercosis; Humans; Mexico; Praziquan	1988
Brain cysticercosis treated with praziquantel. Report of six cases. Acta neurochirurgica, 1988, Volume: 93, Issue:3-4 Topics: Adult; Brain Diseases; Cysticercosis; Female; Humans; Male; Middle Aged; Mycoses; Praziquantel; Tomo	1988
Praziquantel in neurocysticercosis. The Journal of the Association of Physicians of India, 1988, Volume: 36, Issue:2 Topics: Brain Diseases; Cysticercosis; Female; Humans; Middle Aged; Praziquantel; Tomography, X-Ray Computed	1988
[Successful treatment of cerebral cysticercosis with praziquantel]. No shinkei geka. Neurological surgery, 1988, Volume: 16, Issue:9 Topics: Brain Diseases; Cysticercosis; Humans; Male; Middle Aged; Praziquantel; Tomography, X-Ray Computed	1988
Problems in neurocysticercosis after praziquantel therapy. The Journal of the Association of Physicians of India, 1988, Volume: 36, Issue:10 Topics: Brain Diseases; Cysticercosis; Female; Humans; Middle Aged; Praziquantel; Prognosis	1988
[Cutaneous and cerebral cysticercosis. Apropos of a case report in rheumatology]. Revue medicale de la Suisse romande, 1988, Volume: 108, Issue:12 Topics: Adult; Brain Diseases; Cysticercosis; Diagnosis, Differential; Female; Humans; Praziquantel; Skin Di	1988
[Cerebral cysticercosis: imaging, serology, treatment and evolution. Apropos of 2 cases]. Bulletin de la Societe de pathologie exotique et de ses filiales, 1988, Volume: 81, Issue:5 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Brain Diseases; Cysticercosis; Humans; Magnetic Resonanc	1988
Praziquantel (pyrazinoisoquinolone) in active cerebral cysticercosis. Neurosurgery, 1988, Volume: 22, Issue:1 Pt 1 Topics: Adolescent; Adult; Brain Diseases; Child; Child, Preschool; Cysticercosis; Dexamethasone; Drug Thera	1988
Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial. Archives of neurology, 1988, Volume: 45, Issue:5 Topics: Adult; Albendazole; Benzimidazoles; Brain Diseases; Cysticercosis; Female; Humans; Male; Middle Aged	1988
Cerebral cysticercosis successfully treated with praziquantel. Scandinavian journal of infectious diseases, 1988, Volume: 20, Issue:1 Topics: Adult; Brain Diseases; Cysticercosis; Female; Humans; Praziquantel; Tomography, X-Ray Computed	1988
Ataxic hemiparesis from parenchymal brain cysticercosis. Journal of neurology, 1988, Volume: 235, Issue:5 Topics: Adult; Brain Diseases; Cysts; Female; Hemiplegia; Humans; Praziquantel	1988
Cerebral infarct precipitated by praziquantel in neurocysticercosis--a cautionary note. Tropical and geographical medicine, 1988, Volume: 40, Issue:2 Topics: Aphasia; Brain Diseases; Cerebral Infarction; Cysticercosis; Hemiplegia; Hong Kong; Humans; Male; Mi	1988
[Association of cerebral cysticercosis and multifocal glioma. Discussion of interactions]. Revue neurologique, 1987, Volume: 143, Issue:12 Topics: Brain Diseases; Brain Neoplasms; Cysticercosis; Female; Glioma; Humans; Middle Aged; Praziquantel	1987
[An opinion on the treatment of cerebral cysticercosis with pyquiton]. Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry, 1987, Volume: 20, Issue:4 Topics: Animals; Brain; Brain Diseases; Cysticercosis; Cysticercus; Humans; Male; Middle Aged; Praziquantel	1987
[Further study on the effects of pyquiton in treating cerebral cysticercosis and criteria of its evaluation]. Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry, 1987, Volume: 20, Issue:4 Topics: Adolescent; Adult; Brain Diseases; Child; Cysticercosis; Female; Humans; Hydrocephalus; Male; Middle	1987
[Intracranial hypertensive type of cerebral cysticerosis (a report of 33 cases)]. Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry, 1987, Volume: 20, Issue:4 Topics: Adolescent; Adult; Brain Diseases; Cysticercosis; Female; Humans; Male; Middle Aged; Praziquantel; P	1987
[Therapeutic effect of pyquiton in the treatment of 52 cases of cerebral cysticerosis]. Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry, 1987, Volume: 20, Issue:4 Topics: Adolescent; Adult; Brain Diseases; Cysticercosis; Female; Humans; Male; Middle Aged; Praziquantel	1987
Praziquantel therapy in childhood neurocysticercosis. Indian pediatrics, 1987, Volume: 24, Issue:12 Topics: Brain Diseases; Child; Child, Preschool; Cysticercosis; Female; Follow-Up Studies; Humans; Male; Pra	1987
[Neurocysticercosis]. Schweizerische medizinische Wochenschrift, 1986, Aug-30, Volume: 116, Issue:35 Topics: Adult; Brain Diseases; Cerebral Ventriculography; Cysticercosis; Humans; Male; Praziquantel	1986
Selective indications for the use of praziquantel in the treatment of brain cysticercosis. Journal of neurology, neurosurgery, and psychiatry, 1987, Volume: 50, Issue:4 Topics: Brain Diseases; Cerebral Ventriculography; Cysticercosis; Humans; Praziquantel; Tomography, X-Ray Co	1987
Unusual complication in a patient with renal transplantation: cerebral cysticercosis. Nephron, 1987, Volume: 45, Issue:1 Topics: Adolescent; Brain Diseases; Cysticercosis; Enzyme-Linked Immunosorbent Assay; Humans; Kidney Transpl	1987
Cerebral cysticercosis in a European patient: problems of disease activity and therapeutic implications. Klinische Wochenschrift, 1987, May-15, Volume: 65, Issue:10 Topics: Adult; Brain Diseases; Cysticercosis; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Ph	1987
[CT follow-up of neurocysticercosis treated with praziquantel]. Der Radiologe, 1987, Volume: 27, Issue:5 Topics: Adult; Brain Diseases; Cysticercosis; Follow-Up Studies; Humans; Male; Middle Aged; Praziquantel; To	1987
Plasma levels of praziquantel decrease when dexamethasone is given simultaneously. Neurology, 1987, Volume: 37, Issue:9 Topics: Adult; Brain Diseases; Cysticercosis; Dexamethasone; Drug Interactions; Female; Humans; Male; Middle	1987
[Treatment of cysticercosis with praziquantel]. Medicina clinica, 1987, Oct-10, Volume: 89, Issue:11 Topics: Brain Diseases; Cysticercosis; Humans; Praziquantel	1987
Computed axial tomography versus NMR for the diagnosis of neurocysticercosis. Neurochirurgia, 1987, Volume: 30, Issue:5 Topics: Brain Diseases; Cerebral Ventricles; Cysticercosis; Female; Humans; Magnetic Resonance Imaging; Midd	1987
Neurocysticercosis: surgical and medical management with praziquantel. Neurosurgery, 1986, Volume: 18, Issue:4 Topics: Adult; Brain Diseases; Cerebrospinal Fluid Shunts; Craniotomy; Cysticercosis; Female; Humans; Hydroc	1986
[Neurocysticercosis. Diagnostic and therapeutic advances]. Deutsche medizinische Wochenschrift (1946), 1986, Jun-06, Volume: 111, Issue:23 Topics: Adult; Brain Diseases; Combined Modality Therapy; Cysticercosis; Humans; Male; Praziquantel; Tomogra	1986
Cerebral cysticercosis: treatment with praziquantel. Pediatrics, 1986, Volume: 78, Issue:2 Topics: Brain; Brain Diseases; California; Cysticercosis; Drug Therapy, Combination; Female; Hispanic or Lat	1986
[Cerebral manifestation of cysticercosis]. Der Nervenarzt, 1986, Volume: 57, Issue:10 Topics: Brain Diseases; Cysticercosis; Electroencephalography; Evoked Potentials, Auditory; Humans; Magnetic	1986
Long-term results of praziquantel therapy in neurocysticercosis. Journal of neurosurgery, 1987, Volume: 66, Issue:3 Topics: Adolescent; Adult; Aged; Brain Diseases; Child; Child, Preschool; Cysticercosis; Female; Follow-Up S	1987
Albendazole therapy for neurocysticercosis. Archives of internal medicine, 1987, Volume: 147, Issue:4 Topics: Adult; Albendazole; Anthelmintics; Benzimidazoles; Brain Diseases; Cysticercosis; Female; Follow-Up	1987
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 11-1986. A 34-year-old Honduran immigrant woman with intermittent right facial numbness. The New England journal of medicine, 1986, Mar-20, Volume: 314, Issue:12 Topics: Adrenal Cortex Hormones; Adult; Brain; Brain Diseases; Brain Neoplasms; Cysticercosis; Diagnosis, Di	1986
Praziquantel in the treatment of neurocysticercosis: long-term follow-up. Neurology, 1985, Volume: 35, Issue:5 Topics: Adolescent; Adult; Arachnoiditis; Brain Diseases; Cerebrospinal Fluid Proteins; Cysticercosis; Cysts	1985
[Treatment and follow up of 50 cases of cerebral cysticercosis with praziquantel]. Ji sheng chong xue yu ji sheng chong bing za zhi = Journal of parasitology & parasitic diseases, 1985, Volume: 3, Issue:1 Topics: Adult; Brain Diseases; Cysticercosis; Female; Follow-Up Studies; Humans; Isoquinolines; Male; Middle	1985
Neurocysticercosis--a comprehensive approach to medical treatment. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1985, Jul-06, Volume: 68, Issue:1 Topics: Adult; Brain Diseases; Cysticercosis; Drug Therapy, Combination; Female; Humans; Isoquinolines; Male	1985
Case report of a patient having Schistosoma japonicum cerebritis and resolution of CAT brain scan abnormalities without specific antiparasitic therapy. The American journal of tropical medicine and hygiene, 1985, Volume: 34, Issue:4 Topics: Brain Diseases; Humans; Praziquantel; Remission, Spontaneous; Schistosoma japonicum; Schistosomiasis	1985

praziquantel and Brain Disorders